The global Viscosupplementation
Market is witnessing substantial growth as healthcare providers
increasingly adopt minimally invasive therapies for osteoarthritis management.
According to Polaris Market Research, the market was valued at USD 5.81
billion in 2024 and is projected to grow from USD 6.39 billion in 2025
to USD 15.26 billion by 2034, exhibiting a robust CAGR of 10.1% from
2025 to 2034. The growing burden of osteoarthritis, expanding elderly
populations, and rising preference for non-surgical treatment options are
creating favorable conditions for market expansion.
A major contributor to market growth is the increasing
adoption of viscosupplement therapies among patients suffering from
chronic knee pain and degenerative joint disorders. Viscosupplementation
involves injecting hyaluronic acid into affected joints to improve lubrication,
reduce friction, and enhance mobility. These treatments provide significant
benefits for patients seeking alternatives to surgery, making them an
increasingly attractive option in orthopedic care. As awareness of conservative
treatment approaches continues to grow, demand for viscosupplement products is
expected to rise steadily across healthcare systems worldwide.
The expanding viscosupplementation market is closely
linked to the rising prevalence of osteoarthritis, particularly among aging
populations. Osteoarthritis remains one of the leading causes of disability
worldwide, affecting millions of individuals and placing considerable pressure
on healthcare systems. Patients increasingly seek therapies that can provide
long-term symptom relief without the risks and recovery periods associated with
surgical interventions. Viscosupplementation addresses this need by improving
joint function and reducing discomfort, making it a preferred treatment option
for many clinicians and patients.
The growing use of hyaluronic acid injections for knee
osteoarthritis is further supporting market growth. Hyaluronic acid
naturally occurs within synovial fluid and plays a critical role in maintaining
joint lubrication and shock absorption. However, osteoarthritis often leads to
a decline in hyaluronic acid concentration, resulting in pain and reduced
mobility. By restoring these properties through targeted injections, physicians
can help patients achieve improved joint function and enhanced quality of life.
Continuous advancements in formulation technologies, including cross-linked
hyaluronic acid products, are improving treatment effectiveness and durability.
The broader osteoarthritis treatment market is also
benefiting from increasing awareness regarding early intervention and disease
management. Healthcare professionals are emphasizing proactive treatment
strategies designed to delay disease progression and minimize the need for
joint replacement procedures. This trend has encouraged greater adoption of
viscosupplementation as part of comprehensive osteoarthritis management
programs. As healthcare providers continue to promote conservative treatment
options, the market is expected to experience sustained growth throughout the
forecast period.
Read More @ https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market
Another important driver is the growing popularity of knee
pain injection treatment among both physicians and patients. Unlike
surgical procedures that require extended recovery periods, injection-based
therapies offer convenience, faster recovery, and reduced healthcare costs. The
increasing demand for outpatient care and minimally invasive procedures has
further accelerated adoption rates. Polaris Market Research notes that
orthopedic clinics and ambulatory surgery centers are expected to witness the
fastest growth during the forecast period due to increasing patient preference
for specialized and cost-effective treatment settings.
From a product perspective, the three-injection segment
accounted for the largest market share in 2024, reflecting its established
efficacy and widespread use among healthcare providers. Regionally, Asia
Pacific dominated the global market due to its expanding elderly population,
increasing prevalence of knee osteoarthritis, and rising awareness of
non-surgical treatment alternatives. Meanwhile, Europe is expected to register
the fastest growth rate through 2034, supported by growing investments in advanced
osteoarthritis therapies and expanding healthcare access.
As healthcare systems continue prioritizing patient-centered
and minimally invasive treatment approaches, the Viscosupplementation
Market is expected to remain a key segment within musculoskeletal care. Ongoing
advancements in hyaluronic acid technologies, increasing adoption of
injection-based therapies, and rising demand for osteoarthritis management
solutions will continue shaping market growth over the coming decade.
More Trending Latest Reports By Polaris Market Research:
Real
Time Location Systems Market
Fintech
as a Service (FaaS) Market
Biological
Safety Testing Product and Services Market
Pharmacogenomics
Technologies Market
Durable
Medical Equipment Market
Reciprocating
Air Compressor Market
